Back to top
more

STAAR Surgical (STAA)

(Real Time Quote from BATS)

$46.89 USD

46.89
143,756

0.00 (0.00%)

Updated Apr 26, 2024 02:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (71 out of 252)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength?

by Zacks Equity Research

Staar Surgical (STAA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Strength Seen in West Pharmaceutical (WST): Can Its 5.7% Jump Turn into More Strength?

by Zacks Equity Research

West Pharmaceutical (WST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Staar Surgical (STAA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

The headline numbers for Staar Surgical (STAA) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Staar Surgical (STAA) Beats Q4 Earnings Estimates

by Zacks Equity Research

Staar Surgical (STAA) delivered earnings and revenue surprises of 26.32% and 0.30%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Merit Medical (MMSI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Merit Medical (MMSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's What Key Metrics Tell Us About Staar Surgical (STAA) Q3 Earnings

by Zacks Equity Research

While the top- and bottom-line numbers for Staar Surgical (STAA) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Staar Surgical (STAA) Q2 Earnings Beat Estimates

by Zacks Equity Research

Staar Surgical (STAA) delivered earnings and revenue surprises of 25% and 0.79%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

West Pharmaceutical Services (WST) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

West Pharmaceutical (WST) delivered earnings and revenue surprises of 8.21% and 0.16%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Merit Medical (MMSI) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Merit Medical (MMSI) delivered earnings and revenue surprises of 8% and 3.16%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Staar Surgical (STAA) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Staar Surgical (STAA) delivered earnings and revenue surprises of 63.64% and 10.82%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Cardinal Health (CAH) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Merit Medical (MMSI) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Merit Medical (MMSI) delivered earnings and revenue surprises of 16.36% and 5.97%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Staar Surgical (STAA) Q1 Earnings Expected to Decline

by Zacks Equity Research

Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Staar Surgical (STAA) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Staar Surgical (STAA) closed at $62.99 in the latest trading session, marking a +0.24% move from the prior day.

Staar Surgical (STAA) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Staar Surgical (STAA) closed the most recent trading day at $61.70, moving -0.11% from the previous trading session.

Staar Surgical (STAA) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Staar Surgical (STAA) closed the most recent trading day at $63.48, moving +1.6% from the previous trading session.

Staar Surgical (STAA) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Staar Surgical (STAA) closed the most recent trading day at $61.24, moving -1.65% from the previous trading session.

Implied Volatility Surging for STAAR Surgical (STAA) Stock Options

by Zacks Equity Research

Investors need to pay close attention to STAAR Surgical (STAA) stock based on the movements in the options market lately.

Staar Surgical (STAA) Lags Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Staar Surgical (STAA) delivered earnings and revenue surprises of -6.67% and 0.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Henry Schein (HSIC) Matches Q4 Earnings Estimates

by Zacks Equity Research

Henry Schein (HSIC) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Staar Surgical (STAA) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Staar Surgical (STAA) closed at $69.41 in the latest trading session, marking a +1.24% move from the prior day.

Staar Surgical (STAA) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Staar Surgical (STAA) closed the most recent trading day at $77.97, moving -1.73% from the previous trading session.

STAAR Surgical (STAA) to Report Q4 Earnings: What's in Store?

by Zacks Equity Research

Strong growth in EVO ICL units led by increased market adoption is likely to have driven STAAR Surgical's (STAA) Q4 revenues.

STAAR Surgical Company (STAA) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Zacks.com users have recently been watching Staar Surgical (STAA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Cardinal Health (CAH) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Cardinal (CAH) delivered earnings and revenue surprises of 16.81% and 2.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?